WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
People Across China Celebrate Chinese Lunar New YearLaba Festival Gathering for Migrant Children in Xi'anMovies Featuring Women's Strength Popular in China's CinemaChina Adds 2 Golds in Short Track Speed Skating at Gangwon 2024Zheng reaches Australian Open semifinals after fighting winPeople Across China Celebrate Chinese Lunar New YearXinjiang's Urumqi Sees Record Number of Tourists in 2023Across China: A Glimpse into Thriving Ice and Snow Industry in XinjiangChina's Slow Trains Ensure Smooth Trips During Spring Festival Travel RushNPC Deputies Interviewed Before 2nd Plenary Meeting of 2nd Session of 14th NPC
1.6755s , 6496.265625 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Genesis news portal